Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“This week I had the privilege of joining the global hemophilia community at the World Federation of Hemophilia World Congress in Kuala Lampur, Malaysia.
The meeting was nothing short of inspiring—being in the room with clinicians, researchers, patient advocates and people living with hemophilia from around the world was a powerful reminder of why our work matters.
At Sanofi, we remain committed to advancing care for people with rare blood disorders, and moments like these continue to reinforce our team’s sense of urgency and purpose.
I’m grateful for the connections and conversations and look forward to what’s ahead.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring